Evidence map›Paper›PMID 33772056›Full record

ArticleScientific reports2021

Ten-year trends of hypertension treatment and control rate in Korea.

Kwang-Il Kim, Eunjeong Ji, Jung-Yeon Choi, Sun-Wook Kim, Soyeon Ahn, Cheol-Ho Kim

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Management of Hypertension in the Asia-Pacific Region: A Structured Review.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Metabolic risks in living kidney donors in South Korea.Kidney research and clinical practice · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kwang-Il KimDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Eunjeong JiMedical Research Collaborating Center, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Jung-Yeon ChoiDepartment of Internal Medicine, Seoul National University Bundang Hospital, Gumi-ro 173-82, Bundang-gu, Seongnam, Kyeongi, 463-707, Republic of Korea.
Sun-Wook KimDepartment of Internal Medicine, Seoul National University Bundang Hospital, Gumi-ro 173-82, Bundang-gu, Seongnam, Kyeongi, 463-707, Republic of Korea.
Soyeon AhnMedical Research Collaborating Center, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Cheol-Ho KimDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. cheolkim@snu.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We analyzed the Korean National Health and Nutrition Examination Survey (KNHANES) database to determine the trends of hypertension treatment and control rate in Korea over the past 10 years. In addition, we tried to investigate the effect of chronic medical conditions on hypertension management. We investigated the hypertension prevalence, awareness, treatment, and control rate from 2008 to 2017. KNHANES, which uses a stratified multistage sampling design, is a cross-sectional, nationally representative survey conducted by the Korean government. A total of 59,282 adults (≥ 20 years) were included, which was representative of the total population of around 40 million Koreans per year. The mean age was 50.7 ± 16.4 years and 42.6% were male. The prevalence of hypertension, hypercholesterolemia, diabetes mellitus, and obesity significantly increased over the 10 years. During this period, the hypertension treatment and control rate significantly improved. Hypertension treatment rate was significantly lower in the younger age group compared to the older age group, but the control rate among the treated patients was not significantly different between age groups. The treatment and control rates of hypertension were higher in patients with multimorbidity, which implies that it has a favorable effect on the treatment and control of hypertension. Hypertension treatment and control rate have improved over the past 10 years. The higher treatment and control rate in patients with multimorbidity suggest that the more aggressive surveillance might be associated with the improvement of hypertension treatment and control rate in Korea.

Indexed as

Blood PressureChronic DiseaseCross-Sectional StudiesDiabetes MellitusFemaleHealth SurveysHumansHypercholesterolemiaHypertensionMaleMiddle AgedNutrition SurveysObesityRepublic of Korea

Identifiers

PMID33772056
PMCPMC7997987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.